Huntingtin and Other Neurodegeneration-Associated Proteins in the Development of Intracellular Pathologies: Potential Target Search for Therapeutic Intervention

Int J Mol Sci. 2022 Dec 8;23(24):15533. doi: 10.3390/ijms232415533.

Abstract

Neurodegenerative diseases are currently incurable. Numerous experimental data accumulated over the past fifty years have brought us closer to understanding the molecular and cell mechanisms responsible for their development. However, these data are not enough for a complete understanding of the genesis of these diseases, nor to suggest treatment methods. It turns out that many cellular pathologies developing during neurodegeneration coincide from disease to disease. These observations give hope to finding a common intracellular target(s) and to offering a universal method of treatment. In this review, we attempt to analyze data on similar cellular disorders among neurodegenerative diseases in general, and polyglutamine neurodegenerative diseases in particular, focusing on the interaction of various proteins involved in the development of neurodegenerative diseases with various cellular organelles. The main purposes of this review are: (1) to outline the spectrum of common intracellular pathologies and to answer the question of whether it is possible to find potential universal target(s) for therapeutic intervention; (2) to identify specific intracellular pathologies and to speculate about a possible general approach for their treatment.

Keywords: Huntington’s disease; huntingtin; neurodegeneration; neurodegenerative diseases; polyglutamine diseases; proteinopathies.

Publication types

  • Review

MeSH terms

  • Humans
  • Huntingtin Protein / genetics
  • Huntington Disease* / genetics
  • Huntington Disease* / metabolism
  • Huntington Disease* / therapy
  • Neurodegenerative Diseases* / drug therapy

Substances

  • Huntingtin Protein

Grants and funding

This research received no external funding.